Department of Justice accuses Xlear of deceptive advertising; Xlear responds

Last month, the Federal Trade Commission (FTC) sued nasal spray company Xlear for claiming that its xylitol-containing saline nasal spray could help fight COVID-19. Specifically, the FTC alleged that Xlear had violated the COVID-19 Consumer Protection Act.

The Department of Justice also accused the company of violating the Federal Trade Commission Act.

American Fork, Utah–based Xlear released a statement denying the charges, arguing that federal authorities have violated its First Amendment right to free speech.

“Xlear’s response [to the allegations] outlines a series of studies, including two randomized clinical trials (RCTs) and other clinical and lab data, that more than substantiate Xlear’s statements regarding COVID-19,” said Nathan Jones, Xlear’s CEO, in a press release.

Jones cited an RCT that found that the Xlear nasal spray reduced the risk of hospitalization from COVID-19 by a factor of eight.

Xlear has also asserted that its nasa…

Read more
  • 0